CommentaryFull Access
Published Online:1 Feb 2009https://doi.org/10.1176/appi.ajp.2008.08071102
- Cited by
- Contemporary Clinical Trials Communications, Vol. 33
- 10 July 2021 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 271, No. 7
- 23 May 2020 | Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 393, No. 10
- Neuroscience & Biobehavioral Reviews, Vol. 112
- 6 September 2018 | CNS Drugs, Vol. 32, No. 9
- Neuroscience & Biobehavioral Reviews, Vol. 92
- 1 November 2017 | Therapeutic Advances in Psychopharmacology, Vol. 8, No. 1
- British Journal of Hospital Medicine, Vol. 78, No. 9
- 30 April 2012 | Therapeutic Advances in Psychopharmacology, Vol. 2, No. 5
- 5 January 2012 | Australian & New Zealand Journal of Psychiatry, Vol. 46, No. 5
- 22 June 2010 | Journal of Psychopharmacology, Vol. 25, No. 10
- 17 December 2010 | Journal of Psychopharmacology, Vol. 25, No. 10
- 11 March 2011 | Expert Opinion on Drug Discovery, Vol. 6, No. 5
- Science Translational Medicine, Vol. 2, No. 61
- 1 August 2009 | American Journal of Psychiatry, Vol. 166, No. 8
- 1 August 2009 | American Journal of Psychiatry, Vol. 166, No. 8
- 1 August 2009 | American Journal of Psychiatry, Vol. 166, No. 8
- 1 August 2009 | American Journal of Psychiatry, Vol. 166, No. 8
- 1 August 2009 | American Journal of Psychiatry, Vol. 166, No. 8
Metrics
History
Published online 1 February 2009
Published in print 1 February 2009